Cellular Logistics, Inc. (CL) is a U.S. life sciences company that is dedicated to improving the lives of individuals who suffer from heart failure. CL was founded in 2016 by a multi-disciplinary team of physicians, scientists and business entrepreneurs at the University of Wisconsin-Madison. Our vision is to advance myocardial reparative and regenerative therapies that are poised to treat patients with heart failure. Our product, Tandem™ HF, promises to revitalize damaged heart tissue and improve outcomes for the estimated 30 million patients worldwide projected to suffer from heart failure by 2030.